Key Takeaways
- • Han Jiarui's Shenzhen-based ZenX Quant grew assets under management to RMB14bn ($2bn) as of April 2026, up from RMB4bn at end of 2025—a 250% increase driven by strong quantitative strategy performance and renewed institutional demand in China's hedge fund market.
- • ZenX's flagship CSI A500-linked product generated cumulative excess returns exceeding 25 percentage points from end of 2024 through late February 2026, while its small-cap strategy significantly outpaced the CSI 2000 benchmark, demonstrating consistent outperformance relative to underlying indices.
- • The fund's rapid expansion reflects a broader recovery in China's hedge fund industry following years of regulatory constraints, with the rebound in domestic equities since 2025 reviving investor sentiment and improving fundraising conditions for quantitative managers.
- • The number of Chinese hedge funds managing more than RMB10bn has continued to rise in 2026, with international firms remaining relatively limited participants in what remains a largely domestically-focused market structure.
- • Han Jiarui's departure from Citadel Securities in 2021 and subsequent success demonstrates the portability of quantitative trading talent and the market opportunity for experienced quant managers launching vehicles in recovering Asian markets.
Summary
A hedge fund founded by former Citadel Securities executive Han Jiarui has achieved substantial growth in China's recovering hedge fund market, reaching $2 billion in assets under management by April 2026. ZenX Quant, based in Shenzhen, expanded its asset base from approximately RMB4bn at the end of 2025 to RMB14bn ($2bn) within four months, according to investor materials reviewed by Bloomberg. The firm was established by Han in 2021 following his departure from Citadel Securities.
The fund's rapid capital accumulation reflects strong quantitative strategy performance that has driven renewed institutional investor interest. ZenX markets multiple quantitative products focused on Chinese equity benchmarks, with its flagship CSI A500-linked strategy generating cumulative excess returns exceeding 25 percentage points from end of 2024 through late February 2026. A complementary small-cap strategy has similarly outpaced the CSI 2000 benchmark over extended periods. These performance metrics have positioned the firm competitively as investors reassess allocations to quantitative managers following China's equity market recovery since 2025.
ZenX's expansion is emblematic of broader market dynamics in China's hedge fund industry. After several years of regulatory tightening and subdued market conditions, the sector has experienced material recovery, with domestic equity rebound driving improved fundraising conditions. Industry data indicates that the number of Chinese hedge funds managing more than RMB10bn has continued expanding in 2026, reflecting institutional appetite for alternative strategies. However, international firms remain relatively limited participants in the market, with global managers representing only a small portion of China's largest hedge funds.
The case of Han Jiarui demonstrates the strategic value of quantitative expertise and the portability of trading talent across jurisdictions. His transition from a leading global systematic trading platform at Citadel Securities to establishing an independent vehicle in Asia's largest economy illustrates both the availability of capital for experienced quant managers and the competitive opportunity set in emerging hedge fund centers during cyclical recovery phases.
The fund's rapid capital accumulation reflects strong quantitative strategy performance that has driven renewed institutional investor interest. ZenX markets multiple quantitative products focused on Chinese equity benchmarks, with its flagship CSI A500-linked strategy generating cumulative excess returns exceeding 25 percentage points from end of 2024 through late February 2026. A complementary small-cap strategy has similarly outpaced the CSI 2000 benchmark over extended periods. These performance metrics have positioned the firm competitively as investors reassess allocations to quantitative managers following China's equity market recovery since 2025.
ZenX's expansion is emblematic of broader market dynamics in China's hedge fund industry. After several years of regulatory tightening and subdued market conditions, the sector has experienced material recovery, with domestic equity rebound driving improved fundraising conditions. Industry data indicates that the number of Chinese hedge funds managing more than RMB10bn has continued expanding in 2026, reflecting institutional appetite for alternative strategies. However, international firms remain relatively limited participants in the market, with global managers representing only a small portion of China's largest hedge funds.
The case of Han Jiarui demonstrates the strategic value of quantitative expertise and the portability of trading talent across jurisdictions. His transition from a leading global systematic trading platform at Citadel Securities to establishing an independent vehicle in Asia's largest economy illustrates both the availability of capital for experienced quant managers and the competitive opportunity set in emerging hedge fund centers during cyclical recovery phases.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.